热景生物
(688068)
| 流通市值：51.28亿 | | | 总市值：51.28亿 |
| 流通股本：9247.47万 | | | 总股本：9247.47万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 72,745,774.79 | 118,525,855.14 | 234,613,011.59 | 276,112,073.85 |
| 应收票据及应收账款 | 75,099,115.2 | 56,954,580.06 | 40,946,926.23 | 28,601,424.47 |
| 其中：应收票据 | 694,654.8 | 1,823,491.8 | - | 814,330 |
| 应收账款 | 74,404,460.4 | 55,131,088.26 | 40,946,926.23 | 27,787,094.47 |
| 应收款项融资 | - | 187,231.2 | - | - |
| 预付款项 | 24,720,251.4 | 33,676,609.66 | 37,199,063.04 | 22,723,361.07 |
| 其他应收款合计 | 11,685,430.13 | 12,174,447.41 | 9,212,061.57 | 12,328,704.63 |
| 存货 | 115,658,666.1 | 118,295,393.69 | 123,980,835.61 | 136,837,179.07 |
| 一年内到期的非流动资产 | 550,000,000 | 350,000,000 | 350,000,000 | 50,000,000 |
| 其他流动资产 | 28,570,371.31 | 28,092,880.86 | 75,052,916.82 | 33,525,933.13 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,265,944,743.09 | 1,015,904,615.48 | 1,090,874,769.22 | 840,146,256.91 |
| 非流动资产: | | | | |
| 长期股权投资 | 348,915,552.04 | 361,644,653.36 | 377,432,314.25 | 363,785,944.52 |
| 其他权益工具投资 | 123,580,499.79 | 123,580,499.79 | 125,926,516.71 | 105,926,516.71 |
| 其他非流动金融资产 | 419,571,191.78 | 612,627,306.72 | 567,139,915.06 | 948,746,931.52 |
| 固定资产 | 1,111,181,690.57 | 1,109,893,329.58 | 1,122,984,937.81 | 1,130,517,876.82 |
| 在建工程 | 10,308,329.37 | 26,668,132.9 | 74,606,972.17 | 48,184,410.83 |
| 使用权资产 | 7,777,162.15 | 4,873,879.13 | 7,759,390.05 | 13,919,340.6 |
| 无形资产 | 52,353,277.91 | 53,296,027.14 | 54,057,368.82 | 55,067,078.52 |
| 长期待摊费用 | 20,274,217.43 | 19,659,458.54 | 23,022,584.38 | 24,298,522.58 |
| 递延所得税资产 | 29,277,656.05 | 31,631,554.77 | 33,075,885.21 | 34,205,600.21 |
| 其他非流动资产 | 21,600,977.38 | 13,054,708.65 | 8,599,857.22 | 6,762,024.55 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,144,840,554.47 | 2,356,929,550.58 | 2,394,605,741.68 | 2,731,414,246.86 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,410,785,297.56 | 3,372,834,166.06 | 3,485,480,510.9 | 3,571,560,503.77 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 82,118,937.63 | 95,521,112.4 | 114,870,041.48 | 118,194,698.61 |
| 应付账款 | 82,118,937.63 | 95,521,112.4 | 114,870,041.48 | 118,194,698.61 |
| 合同负债 | 16,816,089.03 | 16,277,677.31 | 28,782,474.55 | 28,086,503.1 |
| 应付职工薪酬 | 13,897,307.13 | 18,320,416.76 | 16,163,265.15 | 18,370,780.52 |
| 应交税费 | 4,940,013.34 | 2,064,422.25 | 3,219,393.83 | 2,074,888.46 |
| 其他应付款合计 | 10,070,312.76 | 12,985,347.07 | 10,212,740.58 | 12,636,863.67 |
| 应付股利 | - | 5,178,768.8 | - | - |
| 一年内到期的非流动负债 | 337,403.34 | 2,001,771.82 | 1,916,321.07 | 7,491,884.86 |
| 其他流动负债 | 351,989.03 | 461,169.13 | 708,253.7 | 1,630,840.92 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 128,532,052.26 | 147,631,916.74 | 175,872,490.36 | 188,486,460.14 |
| 非流动负债: | | | | |
| 租赁负债 | 8,144,936.26 | 3,341,653.69 | 6,975,951.13 | 7,763,841.81 |
| 递延收益 | 14,156,311.84 | 15,689,271.84 | 22,491,683.91 | 9,766,683.91 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 22,301,248.1 | 19,030,925.53 | 29,467,635.04 | 17,530,525.72 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 150,833,300.36 | 166,662,842.27 | 205,340,125.4 | 206,016,985.86 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 92,474,692 | 92,474,692 | 92,268,766 | 92,268,766 |
| 资本公积 | 321,374,933.59 | 437,716,263.49 | 442,815,380.71 | 444,038,734.93 |
| 减:库存股 | 92,029,848.33 | 258,510,106.23 | 253,501,962.83 | 166,480,257.89 |
| 其他综合收益 | 2,409,998.97 | 1,749,452.3 | 2,755,914.86 | 4,316,581.98 |
| 盈余公积 | 47,818,114.4 | 47,818,114.4 | 48,148,114.4 | 47,818,114.4 |
| 未分配利润 | 2,887,544,480.28 | 2,884,715,246.5 | 2,944,339,366.5 | 2,945,527,101.24 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,259,592,370.91 | 3,205,963,662.46 | 3,276,825,579.64 | 3,367,489,040.66 |
| 少数股东权益 | 359,626.29 | 207,661.33 | 3,314,805.86 | -1,945,522.75 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,259,951,997.2 | 3,206,171,323.79 | 3,280,140,385.5 | 3,365,543,517.91 |
| 负债和股东权益合计 | 3,410,785,297.56 | 3,372,834,166.06 | 3,485,480,510.9 | 3,571,560,503.77 |
| 公告日期 | 2024-10-31 | 2024-08-30 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |